Akt and CHIP coregulate tau degradation through coordinated interactions

被引:172
作者
Dickey, Chad A. [1 ]
Koren, John [1 ]
Zhang, Yong-Jie [3 ]
Xu, Ya-Fei [3 ]
Jinwal, Umesh K. [1 ]
Birnbaum, Morris J. [4 ,5 ]
Monks, Bobby [4 ,5 ]
Sun, Mei [2 ]
Cheng, An Q. [2 ]
Pattersonl, Cam [6 ]
Bailey, Rachel M. [3 ]
Dunmore, Judith [3 ]
Soresh, Sareh [3 ]
Leon, Carlos [3 ]
Morgan, Dave [1 ]
Petrucelli, Leonard [3 ]
机构
[1] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr, Tampa, FL 33612 USA
[3] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA
[4] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA
[6] Univ N Carolina, Div Cardiol, Chapel Hill, NC 27599 USA
关键词
Alzheimer's disease; cell signaling; chaperone; MARK2/PAR1;
D O I
10.1073/pnas.0709180105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A hallmark of the pathology of Alzheimer's disease is the accumulation of the microtubule-associated protein tau into fibrillar aggregates. Recent studies suggest that they accumulate because cytosolic chaperones fail to clear abnormally phosphorylated tau, preserving a pool of toxic tau intermediates within the neuron. We describe a mechanism for tau clearance involving a major cellular kinase, Akt. During stress, Akt is ubiquitinated and degraded by the tau ubiquitin ligase CHIP, and this largely depends on the Hsp90 complex. Akt also prevents CHIP-induced tau ubiquitination and its subsequent degradation, either by regulating the Hsp90/CHIP complex directly or by competing as a client protein with tau for binding. Akt levels tightly regulate the expression of CHIP, such that, as Akt levels are suppressed, CHIP levels also decrease, suggesting a potential stress response feedback mechanism between ligase and kinase activity. We also show that Akt and the microtubule affinity-regulating kinase 2 (PAR1/MARK2), a known tau kinase, interact directly. Akt enhances the activity of PAR1 to promote tau hyperphosphorylation at S262/S356, a tau species that is not recognized by the CHIP/Hsp90 complex. Moreover, Akt1 knockout mice have reduced levels of tau phosphorylated at PAR1/MARK2 consensus sites. Hence, Akt serves as a major regulator of tau biology by manipulating both tau kinases and protein quality control, providing a link to several common pathways that have demonstrated dysfunction in Alzheimer's disease.
引用
收藏
页码:3622 / 3627
页数:6
相关论文
共 21 条
[1]  
Ballinger CA, 1999, MOL CELL BIOL, V19, P4535
[2]   Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function [J].
Basso, AD ;
Solit, DB ;
Chiosis, G ;
Giri, B ;
Tsichlis, P ;
Rosen, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) :39858-39866
[3]   Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice [J].
Cho, H ;
Thorvaldsen, JL ;
Chu, QW ;
Feng, F ;
Birnbaum, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) :38349-38352
[4]   INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B [J].
CROSS, DAE ;
ALESSI, DR ;
COHEN, P ;
ANDJELKOVICH, M ;
HEMMINGS, BA .
NATURE, 1995, 378 (6559) :785-789
[5]   CHIP activates HSF1 and confers protection against apoptosis and cellular stress [J].
Dai, Q ;
Zhang, CL ;
Wu, YX ;
McDonough, H ;
Whaley, RA ;
Godfrey, V ;
Li, HH ;
Madamanchi, N ;
Xu, W ;
Neckers, L ;
Cyr, D ;
Patterson, C .
EMBO JOURNAL, 2003, 22 (20) :5446-5458
[6]  
Dickey CA, 2003, J NEUROSCI, V23, P5219
[7]   The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins [J].
Dickey, Chad A. ;
Kamal, Adeela ;
Lundgren, Karen ;
Klosak, Natalia ;
Bailey, Rachel M. ;
Dunmore, Judith ;
Ash, Peter ;
Shoraka, Sareh ;
Zlatkovic, Jelena ;
Eckman, Christopher B. ;
Patterson, Cam ;
Dickson, Dennis W. ;
Nahman, N. Stanley, Jr. ;
Hutton, Michael ;
Burrows, Francis ;
Petrucelli, Leonard .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) :648-658
[8]   Current strategies for the treatment of Alzheimer's disease and other tauopathies [J].
Dickey, Chad A. ;
Petrucelli, Leonard .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (05) :665-676
[9]   HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites [J].
Dickey, Chad A. ;
Dunmore, Judith ;
Lu, Bingwei ;
Wang, Ji-Wu ;
Lee, Wing C. ;
Kamal, Adeela ;
Burrows, Francis ;
Eckman, Christopher ;
Hutton, Michael ;
Petrucelli, Leonard .
FASEB JOURNAL, 2006, 20 (02) :753-+
[10]   Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species [J].
Dickey, Chad A. ;
Yue, Mei ;
Lin, Wen-Lang ;
Dickson, Dennis W. ;
Dunmore, Judith H. ;
Lee, Wing C. ;
Zehr, Cynthia ;
West, Gemma ;
Cao, Songsong ;
Clark, Amber M. K. ;
Caldwell, Guy A. ;
Caldwell, Kim A. ;
Eckman, Christopher ;
Patterson, Cam ;
Hutton, Michael ;
Petrucelli, Leonard .
JOURNAL OF NEUROSCIENCE, 2006, 26 (26) :6985-6996